The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Subscribe To Our Newsletter & Stay Updated
